Novel transcript, antisense to NCMAP (ENSG00000298126)

"Novel transcript, antisense to NCMAP" (ENSG00000298126) is a long non-coding RNA transcribed from the strand opposite to the protein-coding *NCMAP* gene. As a natural antisense transcript, it is believed to influence the expression, splicing, or stability of the sense (*NCMAP*) mRNA through mechanisms such as transcriptional interference, RNA masking, or formation of double-stranded RNA, potentially affecting gene regulation at the transcriptional or post-transcriptional level. While natural antisense transcripts as a class are increasingly recognized as regulators of gene expression and may play roles in disease through epigenetic silencing or promotion of specific isoforms, there is currently no evidence that this specific NAT is itself a receptor, enzyme, transporter, or direct therapeutic target, nor is there evidence for drug interactions or use as a biomarker[1][2][3][4].

Other names

ENSG00000298126

Transcriptional interference; RNA masking; Double-stranded RNA-mediated silencing (RNA interference, siRNA formation); Chromatin remodeling.